Stock 4595 MIZUHO MEDY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Mizuho Medy Co.,Ltd.

Equities

4595

JP3885900005

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-06-28 am EDT 		5-day change 1st Jan Change
1,622 JPY -3.51% Intraday chart for Mizuho Medy Co.,Ltd. -2.58% +3.31%
2021 Mizuho Medy Co.,Ltd.(TSE:4595) added to S&P Global BMI Index CI
2020 Mizuho Medy Co.,Ltd.(TSE:4595) dropped from S&P Global BMI Index CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • The company is one of the best yield companies with high dividend expectations.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • The company's earnings growth outlook lacks momentum and is a weakness.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
MIZUHO MEDY CO.,LTD. Stock Mizuho Medy Co.,Ltd.
+3.31% 192M -
BIOMÉRIEUX Stock bioMérieux
-11.78% 11.24B
B+
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-13.76% 7.29B
B-
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+29.50% 5.57B
C
DIASORIN S.P.A. Stock DiaSorin S.p.A.
-0.19% 5.31B
B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
-19.19% 3.68B
C
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+7.62% 2.58B - -
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-65.24% 2.33B
D+
VITROLIFE AB Stock Vitrolife AB
-10.48% 2.23B
B-
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+27.80% 2.21B
C
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
-
Potential Price Target
-
4m Target Price Revision
-
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 4595 Stock
  4. Ratings Mizuho Medy Co.,Ltd.